Bleepa achieves CE Mark - Raising the bar for medical communication platforms

Bleepa appointed to major NHSx framework

30/07/20

Uncategorised

Bleepa® to lead clinical communications revolution through appointment to major NHSx framework

● NHSx Clinical Communication Tool Framework endorses Bleepa and provides route to payment

● The Directors believe that as the only CE marked product for digital patient imaging on the framework Bleepa is the only provider that can deliver digital imaging as part of the communication service

London, 30 July 2020: Feedback plc (AIM: FDBK, “Feedback” or the “Company”), the specialist medical imaging technology company, today announces that its flagship imaging-based communication platform, Bleepa, has been awarded a place on the NHSx National Clinical Communication Tool Framework (“the NCCT Framework”). Bleepa is a clinical communications platform that combines access to review quality medical imaging alongside instant messaging and video calling in one CE marked, zero footprint, medical device.

The NCCT Framework provides a vehicle for NHS Trusts to buy Bleepa by drawing down from a £3 million centralised fund over a two year period. It gives Bleepa national coverage and provides an independent validation of the quality and suitability of Bleepa for frontline delivery, a stamp of approval that the Company can use to also drive sales in other markets.

The Directors believe that as the only CE marked medical device relating to medical imaging on the NCCT Framework, Bleepa is the only supplier able to deliver digital patient imaging for diagnostic purposes alongside clinical messaging. The Directors believe that Bleepa’s simple messaging exchange will offer considerable benefit to clinicians and Trusts, enabling the NHS to purge the pager and replace it with a truly transformative solution that brings medical imaging into routine communication.

Dr Tom Oakley, CEO of Feedback, commented:

“Bleepa has set a new standard for medical communication tools. I am delighted Bleepa has been awarded a place on the NHSx Clinical Communication Tool framework which positions Bleepa in the vanguard of medical imaging communications and provides a vehicle for potential reimbursement whilst simultaneously making Bleepa available to the whole of the NHS.”

 


Below is the full announcement made today by NHSx:

Clinical Communications Procurement Framework

The Procurement Framework aims to support NHS organisations with dedicated clinical facing communication and tasks management tools, to accelerate the adoption of proven technologies and to phase out pagers by the end of 2021.

The framework has been designed to provide a compliant and convenient route to market for all NHS organisations.

It allows clinicians to access a wide range of communication tools all under one procurement framework agreement. Participating authorities have the freedom and flexibility to make a direct award or undertake a mini-competition to meet the bespoke requirement of each customer.

The suppliers have been assessed to ensure that they meet all legislative requirements; therefore no formal tendering is required, saving valuable time and money in the procurement process. The framework contains large national companies but also a healthy number of regional SMEs, and all can showcase their products via the framework, helping buyers to make informed local decisions.

Framework date and duration

3 August 2020 to 3 August 2022. Possible further extension for 12 months.

Further information is available on the NHSx website at https://www.nhsx.nhs.uk/key-tools-and-info/clinical-communications-procurement-framework/